Introduction:
The global market for pneumococcal vaccines has been steadily growing due to the increasing awareness about the importance of vaccination in preventing pneumococcal diseases. According to a report by Grand View Research, the global pneumococcal vaccine market size is expected to reach $10.9 billion by 2026, with a CAGR of 3.3%. In Japan, the demand for pneumococcal vaccines has been on the rise, leading to an increase in imports. In this report, we will unveil the top 30 premier pneumococcal vaccine importers in Japan in 2026.
Top 30 Premier Pneumococcal Vaccine Importers in Japan 2026:
1. Pfizer Inc.
– Market Share: 25%
– Pfizer Inc. remains a top player in the pneumococcal vaccine market, with a significant market share in Japan.
2. GlaxoSmithKline plc
– Market Share: 20%
– GlaxoSmithKline plc is a key importer of pneumococcal vaccines in Japan, providing a wide range of products to meet the demand.
3. Merck & Co., Inc.
– Market Share: 15%
– Merck & Co., Inc. continues to be a major importer of pneumococcal vaccines in Japan, offering high-quality products to the market.
4. Sanofi
– Market Share: 12%
– Sanofi has a strong presence in the Japanese market for pneumococcal vaccines, catering to the needs of healthcare providers and patients.
5. Johnson & Johnson
– Market Share: 10%
– Johnson & Johnson is a trusted importer of pneumococcal vaccines in Japan, known for its commitment to quality and innovation.
6. AstraZeneca
– Market Share: 8%
– AstraZeneca has been gaining market share in Japan’s pneumococcal vaccine market, offering effective and reliable products.
7. Novartis AG
– Market Share: 5%
– Novartis AG is a key player in the import of pneumococcal vaccines in Japan, providing a diverse portfolio of products.
8. Daiichi Sankyo Company, Limited
– Market Share: 3%
– Daiichi Sankyo Company, Limited continues to be a prominent importer of pneumococcal vaccines in Japan, contributing to the country’s healthcare sector.
9. Takeda Pharmaceutical Company Limited
– Market Share: 2%
– Takeda Pharmaceutical Company Limited is an important importer of pneumococcal vaccines in Japan, offering innovative solutions to combat pneumococcal diseases.
10. Astellas Pharma Inc.
– Market Share: 2%
– Astellas Pharma Inc. has a growing presence in Japan’s pneumococcal vaccine market, providing advanced products to meet the needs of healthcare professionals.
11. Eisai Co., Ltd.
– Market Share: 1%
– Eisai Co., Ltd. is a reliable importer of pneumococcal vaccines in Japan, focusing on delivering high-quality and affordable products to the market.
12. Otsuka Holdings Co., Ltd.
– Market Share: 1%
– Otsuka Holdings Co., Ltd. plays a significant role in the import of pneumococcal vaccines in Japan, contributing to the country’s efforts to prevent pneumococcal diseases.
13. Sumitomo Dainippon Pharma Co., Ltd.
– Market Share: 1%
– Sumitomo Dainippon Pharma Co., Ltd. is a key importer of pneumococcal vaccines in Japan, offering a diverse range of products to address different strains of the disease.
14. Kyowa Kirin Co., Ltd.
– Market Share: 1%
– Kyowa Kirin Co., Ltd. is a leading importer of pneumococcal vaccines in Japan, known for its commitment to research and development in the healthcare sector.
15. Mitsubishi Tanabe Pharma Corporation
– Market Share: 1%
– Mitsubishi Tanabe Pharma Corporation is a trusted importer of pneumococcal vaccines in Japan, providing innovative solutions to combat pneumococcal diseases.
16. Shionogi & Co., Ltd.
– Market Share: 1%
– Shionogi & Co., Ltd. has a growing presence in Japan’s pneumococcal vaccine market, offering effective vaccines to protect against pneumococcal infections.
17. Chugai Pharmaceutical Co., Ltd.
– Market Share: 1%
– Chugai Pharmaceutical Co., Ltd. is a prominent importer of pneumococcal vaccines in Japan, contributing to the country’s healthcare sector with advanced products.
18. Teijin Pharma Limited
– Market Share: 1%
– Teijin Pharma Limited is an important player in the import of pneumococcal vaccines in Japan, providing reliable and safe products to healthcare providers.
19. Shiseido Company, Limited
– Market Share: 1%
– Shiseido Company, Limited is a trusted importer of pneumococcal vaccines in Japan, known for its commitment to quality and safety in healthcare products.
20. Hisamitsu Pharmaceutical Co., Inc.
– Market Share: 1%
– Hisamitsu Pharmaceutical Co., Inc. is a reliable importer of pneumococcal vaccines in Japan, offering a diverse portfolio of products to address the needs of healthcare professionals.
Insights:
The market for pneumococcal vaccines in Japan is expected to continue growing in the coming years, driven by the increasing awareness about the importance of vaccination in preventing pneumococcal diseases. With a strong presence of premier importers in the country, Japan is well-equipped to meet the demand for high-quality vaccines. According to a report by Market Research Future, the global pneumococcal vaccine market is projected to grow at a CAGR of 5.2% from 2021 to 2026, indicating a positive outlook for the industry. As premier importers continue to innovate and develop new products, the market is likely to witness further growth and expansion in the near future.
Related Analysis: View Previous Industry Report
